StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific Free Cash Flow = Operating Cash Flow − Net CapEx by Quarter

Free Cash Flow = Operating Cash Flow − Net CapEx ($M)

QuarterlyAnnual

Thermo Fisher Scientific Free Cash Flow = Operating Cash Flow − Net CapEx: $2,115M in Q3 2026, up 14.9% from a year earlier.

Latest, Q3 2026
2,115
Period ended Sep 30, 2026
Change on a year earlier
+14.9%
1,840 in Q3 2025
History
19 quarters
Since Q1 2022
Sources
7
Documents cited below

Where the Q3 2026 figure comes from

“Free cash flow (non-GAAP measure) 373 1,105 1,840 3,018 825 1,678 2,115”

Source: Q3 2026 Reconciliation of Financial Information ↗

Reported in IR Financial Reconciliation Package & SEC 8-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedFree Cash Flow = Operating Cash Flow − Net CapEx ($M)Year on yearSource
Q3 2026Sep 30, 20262,115+14.9%Q3 2026 Reconciliation of Financial Information ↗
Q2 2026Jun 30, 20261,678+51.9%Q3 2026 Reconciliation of Financial Information ↗
Q1 2026Mar 31, 2026825+121.2%Q3 2026 Reconciliation of Financial Information ↗
Q4 2025Dec 31, 20253,018+6.8%Q3 2026 Reconciliation of Financial Information ↗
Q3 2025Sep 30, 20251,840-3.9%Q3 2026 Reconciliation of Financial Information ↗
Q2 2025Jun 30, 20251,105-34.0%Q3 2026 Reconciliation of Financial Information ↗
Q1 2025Mar 31, 2025373-58.9%Q3 2026 Reconciliation of Financial Information ↗
Q4 2024Dec 31, 20242,826-15.1%Q4 & FY2025 Reconciliation of Financial Information ↗
Q3 2024Sep 30, 20241,915-10.8%Q4 & FY2025 Reconciliation of Financial Information ↗
Q2 2024Jun 30, 20241,674+32.9%Q4 & FY2025 Reconciliation of Financial Information ↗
Q1 2024Mar 31, 2024908+227.8%Q4 & FY2025 Reconciliation of Financial Information ↗
Q4 2023Dec 31, 20233,329+13.1%Q4 & FY2024 Reconciliation of Financial Information ↗
Q3 2023Sep 30, 20232,148+54.1%Q4 & FY2024 Reconciliation of Financial Information ↗
Q2 2023Jun 30, 20231,260+21.9%Q4 & FY2024 Reconciliation of Financial Information ↗
Q1 2023Mar 31, 2023277-82.3%Q4 & FY2024 Reconciliation of Financial Information ↗
Q4 2022Dec 31, 20222,943–SEC Form 8-K (8k_2023Q4, filed 2024-01-31) ↗

Cite this data

StockData. (2026). Thermo Fisher Scientific Free Cash Flow = Operating Cash Flow − Net CapEx ($M), quarterly Q1 2022–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/fcf-non-gaap

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.